Skip to main content
. 2017 Jun 27;8(41):69622–69640. doi: 10.18632/oncotarget.18710

Figure 7. ESE-1 KD inhibits tumor formation in NOD/SCID female mice.

Figure 7

(A) BT474 cells transduced with either shScr or shESE-1 were injected into mammary fat pads of NOD/SCID mice to establish tumor xenografts. Tumor growth is shown as IVIS signaling at weeks 1, 2 and 5 post injection. (B) Total photon flux from tumors derived from shScr control cells and derived from shESE-1 knocked down cells is shown over 5 weeks. (C) Sacrificed tumor sizes in shSchr control and shESE-1 knockdown groups. Tumors sizes were measured using the modified ellipsoid formula, Tumor volume = ½(length * width^2).